Accenture Stock Jumps 20% as Record Bookings Dispel AI Fears

For most of this year, Accenture looked like one of AI's biggest potential casualties. Thursday, the company flipped that narrative hard — and the stock moved like it.

Shares of Accenture (NYSE: ACN) surged more than 20% in early trading after the consulting giant posted fiscal fourth-quarter results that crushed the market's biggest fear: that generative AI would gut demand for traditional consulting and IT services work.

The numbers back up the relief rally. Revenue grew 6% to $18.7 billion, topping the high end of Accenture's own guidance range of $17.75 billion to $18.40 billion and beating the $18.03 billion analyst average. Diluted earnings per share hit $3.29, up 46% from a year earlier. Operating margin expanded 370 basis points to 15.3%.

The real headline, though, is bookings. Accenture landed a record 141 client deals worth $100 million or more in the quarter, pushing full-year bookings to an all-time high of $84.5 billion. New bookings for the quarter alone reached $22.17 billion, up 5% in local currency, split between $9.40 billion in consulting and $12.77 billion in managed services.

That's the story investors needed to see. Accenture stock had been down roughly 30% year-to-date heading into Wednesday's close, as the market priced in a future where AI automates away the exact services the company sells.

Accenture's full-year bookings reached an all-time high of $84.5 billion, with a record 141 client deals worth $100 million or more landing in the fourth quarter alone.

Accenture's counter has been to position itself as the company that helps other businesses deploy AI safely, not the company AI replaces. In September it announced a partnership with Anthropic to embed dedicated safety experts inside the AI lab to stress-test models before they ship — a deal where both companies plan to invest at least $1 billion each over the next five years.

Not everyone's fully convinced yet. Jefferies reiterated a Hold rating with a $190 price target after the report, and TD Cowen kept its Hold rating with a $173 target — both well below the roughly $216 level shares were trading at in Thursday's premarket session. Jefferies flagged that Accenture's fiscal 2027 guidance of 3% to 6% total growth implies organic growth of only about 0.5% to 3.5% once you strip out the 2.5 percentage points management says will come from acquisitions.

That's the real tension for anyone weighing a position here. The headline growth number looks solid, but a meaningful chunk is inorganic, and the stock just ran 20% in a single session on the back of it. TD Cowen's take was similar — acquisitions are doing real work in that outlook, even as the firm acknowledged Q4 results beat both its own estimates and the Street's more cautious expectations.

For fiscal 2027, Accenture guided to diluted EPS of $14.39 to $14.81, an operating margin of 15.9% to 16.1%, and free cash flow of $11.0 billion to $11.8 billion. Management also said discretionary client spending held roughly steady in the quarter — a detail worth tracking, since the low end of next year's guidance assumes some deterioration there.

If you're looking at ACN after this move, the entry point question comes down to whether you believe the AI-anxiety discount is now fully gone or just partially priced out. With the stock still down for the year even after today's pop, there's an argument the re-rating has further to run if bookings momentum holds into the next couple of quarters.

The bottom line: Accenture didn't just beat estimates, it answered the single biggest question hanging over the stock all year. Whether that's worth a 20% repricing in one day is now up to the next few quarters of bookings data to prove.